IMARC Group has recently released a new research study “Real-World Evidence Solutions Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of the Real-World Evidence Solutions Industry ?
The global Real-World Evidence Solutions Market size reached US$ 1.41 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.01 Billion by 2027, exhibiting a growth rate (CAGR) of 12.70% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
What is Real-World Evidence Solutions Market ?
Real-world evidence (RWE) represents clinical evidence about the use and potential benefits or risks of medical products through real-world data (RWD). It can be produced via several study designs or analysis, such as randomized trials, big simple trials, pragmatic trials, observational studies, etc.
Real-world evidence provides insight into real-world treatment patterns in patient groups, including dosing, compliance, adherence, off-label use, etc., and the balance between efficacy and safety. It can also help researchers in discovering possible patients and developing correct inclusion criteria for clinical trials, which can aid them in designing better pre-trial studies.
Request For Sample Report:https://www.imarcgroup.com/real-world-evidence-solutions-market/requestsample
What are the major market drivers in the Real-World Evidence Solutions Market:
The escalating demand for RWE solutions to get precise and clear information about the safety and efficacy of new products is among the key factors augmenting the real-world evidence solutions market.
Furthermore, the elevating requirement for these solutions to detect varied reactions, item subpopulation effects, and product value when used by complex and comorbid patients is acting as another significant growth-inducing factor.
Moreover, the growing healthcare sector is also bolstering the global market.
Besides this, the increasing utilization of advanced analytics and technological solutions in RWE for clinical developments, commercialization, speed innovations, and accelerating improvements in healthcare outcomes is further catalyzing the market growth. Additionally, the expanding usage of RWE solutions by numerous government bodies of various countries to monitor the efficacy of drugs and vaccines is also driving the global market.
Apart from this, the shifting preferences from volume to value-based care are fueling the market growth. Furthermore, the inflating digitalization levels and the emerging trend of patient-centered virtual care are expected to positively influence the real-world evidence solutions market in the coming years.
Who are the leading players in the Real-World Evidence Solutions Market ?
Aetion Inc., Clinigen Limited, Flatiron Health Inc. (Roche Holding AG), ICON plc, International Business Machines Corporation, IQVIA, Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation, Parexel International Corporation, PPD Inc. (Thermo Fisher Scientific Inc.), Sas Institute Inc. and Syneos Health.
| Real-World Evidence Solutions Market | |
| Report Coverage | Details |
| Market size value in 2021 | US$ 1.41 Billion |
| Market forecast in 2027 | US$ 3.01 Billion |
| Growth Rate | CAGR of 12.70% from 2022 to 2027 |
| Base year for estimation | 2021 |
| Historical data | 2016-2021 |
| Forecast period | 2022-2027 |
| Report coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends |
| Segments covered | Component, Therapeutic Area And End User |
| Regional scope | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Key companies profiled | Aetion Inc., Clinigen Limited, Flatiron Health Inc. (Roche Holding AG), ICON plc, International Business Machines Corporation, IQVIA, Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation, Parexel International Corporation, PPD Inc. (Thermo Fisher Scientific Inc.), Sas Institute Inc. and Syneos Health. |
| Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Report Segmentation: The report has been segmented the market into following categories:Breakup by Component:
Breakup by Therapeutic Area:
Breakup by End User:
By Geography:
Key highlights of the report:
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800